If you have type 2 diabetes, your healthcare provider may prescribe Tradjenta. This medication works by increasing insulin levels and decreasing the amount of glucose (sugar) produced by the liver. This medicine comes in the form of a tablet that is taken once daily. Some of the most common side effects of this drug include a sore throat and a runny or stuffy nose.
Tradjenta is marketed by Boehringer Ingelheim Pharmaceuticals, Inc., and Eli Lilly and Company.
How Does Tradjenta Work?
Tradjenta is part of a class of diabetes medications called dipeptidyl peptidase-4 (DPP-4) inhibitors. DPP-4 is an enzyme that breaks down incretin hormones. As a DPP-4 inhibitor, Tradjenta slows down the breakdown of incretin hormones, increasing the level of these hormones in the body. It is this increase in incretin hormones that is responsible for the beneficial actions of Tradjenta, such as increasing insulin production in response to meals and decreasing the amount of glucose (sugar) that the liver produces.
Because incretin hormones are more active in response to higher blood sugar levels, the risk of dangerously low blood sugar levels (hypoglycemia) is low with Tradjenta.
Food and Drug Administration, Center for Drug Evaluation and Research. Electronic orange book: approved drug products with therapeutic equivalence evaluations. FDA Web site. Available at: http://www.fda.gov/cder/ob/. Accessed September 9, 2011.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind.
Site users seeking medical advice about their specific situation should consult with their own physician. Click